The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2017

Filed:

Feb. 27, 2014
Applicants:

Simon Glerup Pedersen, Risskov, DK;

Ulrich Bolcho, Harlev, DK;

Kimmo Jensen, Arhus V, DK;

Anders Nykjaer, Risskov, DK;

Inventors:

Simon Glerup Pedersen, Risskov, DK;

Ulrich Bolcho, Harlev, DK;

Kimmo Jensen, Arhus V, DK;

Anders Nykjaer, Risskov, DK;

Assignee:

H. Lundbeck A/S, Valby, DK;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); C07K 14/705 (2006.01); A61K 38/12 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); G01N 33/94 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
C07K 14/705 (2013.01); A61K 38/12 (2013.01); A61K 38/177 (2013.01); A61K 38/185 (2013.01); A61K 39/395 (2013.01); A61K 45/06 (2013.01); C07K 14/47 (2013.01); C07K 16/286 (2013.01); G01N 33/94 (2013.01); A01K 2217/075 (2013.01); G01N 2333/705 (2013.01); G01N 2800/28 (2013.01);
Abstract

The present invention relates to methods for modulating the activity of one or more Vps10p-domain receptors selected from the group consisting of Sortilin, SorLA, SorCS1, SorCS2 and SorCS3, in an animal and methods for preparation of a medicament for the treatment of mental and behavioral disorders. The modulation is carried out by inhibiting or promoting the binding of ligands to the Vps10p-domain receptor. In vitro and in vivo methods for screening for agents capable of modulation of said Vps10p-domain receptor activity are also provided. The invention furthermore relates to methods of altering expression of said receptors in vivo.


Find Patent Forward Citations

Loading…